America & Europe Eye Drops Market Size and Forecast (2021-2031)
America & Europe Eye Drops Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class [Antibiotics (Moxifloxacin, Ciprofloxacin, Gentamycin, Chloramphenicol, and Others), Artificial Tears (Carboxymethylcellulose, Polyethylene Glycol, and Others), Steroids (Dexamethasone, Loteprednol, Fluocinolone, and Others), and Others], Application [Eye Diseases (Dry Eye, Cataract, Glaucoma, Refractive Error, and Others), Eye Care, and Others], Purchase Mode (Prescription and OTC), and Geography (America and Europe)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Most people who suffer from eye problems need special eye drops. These eye diseases can be treated with eye drops, which are more effective and less painful. Symptoms such as dry eye, redness, pain, itching, glaucoma, refractive error, conjunctivitis, diabetic macular edema, and age-related macular degeneration can be effectively treated using these products. Eye drops, also called artificial tears, are a class of therapeutics commonly used to simultaneously relieve the symptoms of dry and irritated eyes by moisturizing the eyes and protecting them from further infection. Pollution, changing lifestyles, and prolonged screen time are the prominent causes of eye pain. These factors and environmental conditions propel the demand for eye drops that provide relief and protection. The availability of a wide range of eye drops that can be purchased without a prescription has made it easier for customers to procure them.
Rising Prevalence of Ophthalmic Diseases Drives the America & Europe Eye Drops Market
The Incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye disease (DED) is rising in the populations of various countries, especially the developed ones. DED causes discomfort, irritation, and visual disturbance in patients. Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema (DME) may also become apparent, leading to vision problems and blindness. According to the “National Health and Wellness Survey,” ~16.4 million people were detected with dry eye in the US as of April 2020. The study highlights an upsurge in prevalence by 2.7% among people aged 18−34 years during 2020. According to Novaliq GmbH, ~13 million Europeans and ~17 million Americans suffered from DED as of 2023. As per Santen Pharmaceuticals, nearly 11–30% of people in Europe suffered from DED in 2021. Data released on Medscape website states that ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually. Further, as per the International Diabetes Federation Europe, 20–35% of people with diabetes are at risk of developing diabetic retinopathy. The prevalence of DME in people with type 1 diabetes is approximately 8.8% in Europe.
Cataracts, which are highly common in elderly people, are characterized by the formation of a cloudy area in the eye lens. According to the article “Cataract surgery practice patterns worldwide: a survey,” published in BMJ, cataract extraction is the most common surgical procedure in all medical specialties, with an estimated 3.7 million cases per year in the US and 7 million cases reported in Europe. As per Eurostat, cataract surgery was the most common surgical procedure in the EU, with 4.32 million operations in 2021. According to Santen Pharmaceuticals, the number of people suffering from glaucoma is estimated to soar up to ~7.85 million in Europe by 2040.
Doctors generally prescribe eye drops for the treatment, prevention, and post-surgical care of various ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases fuels the America & Europe eye drops market growth.
Market Trend
Lifestyle Changes Affecting Eye Health
Lifestyle factors can impact the overall health and well-being. The choices made by people every day with regard to their food, fitness, outdoor activities, etc., affect how well they age. The aging process also involves changes in eye health and vision. Heavy sun exposure on a frequent basis can increase the risk of developing eye diseases. As per the American Academy of Ophthalmology, exposure to the sun’s UV rays can increase the risk of macular degeneration and cataracts. Being overweight can increase the risk of eye problems in several ways. Overweight and obesity increase the risk of developing diabetes, which can lead to vision loss from diseases such as diabetic retinopathy and glaucoma. Further, non-prescription medications taken to improve quality of life can also cause side effects similar to those of prescription medications. The rapid increase in DED cases in recent years is believed to be due to prolonged exposure to visual display devices (VDT) caused by increasing computer use. Many aspects of everyday life can have unforeseen effects on the ocular surface and the eye. The increased use of smartphones, laptops, and computers is one of the key risk factors for eye diseases. Hence, these diseases hold a substantial share of the overall category of lifestyle diseases. Thus, increased screen time has become an important aspect of a modern lifestyle, which is responsible for triggering eye-related problems. Individuals with chronic eye conditions and refractive errors are at a greater risk of developing digital eye strain (DES). DES often manifests as discomfort, dryness, blurred vision, and headaches. Extreme exposure to blue rays emitted from smartphone, tablet, iPad, and laptop screens also causes serious eye damage.
During the COVID-19 pandemic, all companies opted to adopt the work-from-home (WFH) model to control the disease spread. The growing trend of WFH has intensified the screen time of working professionals, further accelerating the number of eye-related issues. According to a study published by Frontiers, the constant use of digital devices for more than two continuous hours puts users at a great risk of developing DES owing to the excessive accommodative demands. Although the spread of COVID-19 has been controlled to a large extent, many companies have allowed their employees to continue with WFH to decrease the overall expenditure. Such lifestyle changes are eventually expected to have negative effects on eye health in the long run, generating a greater demand for eye drops in the future.
The “America & Europe Eye Drops Market” is segmented on the basis of drug class, application, purchase mode, and geography.
Drug Class-Based Insights
Based on drug class, the America & Europe eye drops market is segmented into antibiotics, artificial tears, steroids, and others. The antibiotics segment held the largest market share in 2023. However, the steroids segment is anticipated to register the highest CAGR of 6.4% during the forecast period. Antibiotic eye drops are prescribed by doctors to treat antibacterial infections. The action of these eye drops starts with the penetration of multiple tissue layers of the eye before acting on the infection. In most cases, antibiotic eye drops provide immediate relief from the condition. Most antibiotic eye drops are safe and have minimal side effects. Different antibiotics that are offered in the form of eye drops include chloramphenicol, erythromycin, azithromycin, ciprofloxacin, neomycin, moxifloxacin, tobramycin, bacitracin, gentamycin, polymyxin B, gatifloxacin, besifloxacin, and levofloxacin. In addition to their efficacy, their beneficial role in rectifying the malfunctioning of meibomian glands contributes to the growth of the market for antibiotic eye drops.
Application-Based Insights
Based on process, the America & Europe eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest market share in 2023. However, the eye care segment is anticipated to register the highest CAGR during the forecast period.
US Food and Drug Administration, World Health Organization, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, United Nations Fund for Population Activities, and Global Burden of Disease are some of the relevant sources referred while preparing the America & Europe eye drops market research report.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | Central America & Caribbean, Europe, North America, South America |
| Year of Publication: |
Factors such as the rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases propel the market growth. However, the rising number of product recalls impede the America & Europe eye drops market growth.
Initiatives to Bolster Eye Care Awareness Creates Opportunities for the America & Europe Eye Drops Market
In recent years, efforts have been made to create awareness and educate people regarding eye diseases, prompting patients to access suitable medications and treatments. In 2017, the National Eye Institute (NEI) in the US initiated “Write the Vision,” a new eye health awareness program, to build awareness about eye health, specifically targeting African American consumers. The “Write the Vision” program offers monthly resources to a large number of organizations, allowing them to promote healthy vision and prevent vision loss as well as blindness in the communities they serve. As per the National Eye Health Education Program, a part of the NEI, African Americans are more prone to eye diseases, which can result in vision loss if not treated in time. On August 28, 2023, the Centers for Disease Control and Prevention partnered with other organizations committed to vision health under its Vision Health Initiative (VHI) to create a more effective multi-tiered network to prevent vision loss and support eye health. The VHI has the unique mission of working with state and national partners to strengthen science and develop interventions for improving eye health, reducing vision loss and blindness, and promoting the health of people with vision loss. On December 27, 2023, Prevent Blindness (an eye health and safety organization in the US) announced its plan to participate in the National Glaucoma Awareness Month campaign in January 2024 to provide patients, care partners, and professionals with various helpful resources to educate them on glaucoma. On October 12, 2023, the organization joined the International Agency to Prevent Blindness and other eye health organizations worldwide to raise awareness of vision and eye health problems to promote access to eye care as part of World Sight Day. On October 1, 2023, 2EyesVision proudly reaffirmed its commitment to shaping the future of ophthalmology through community initiatives of the Ministry of Industry, Trade and Tourism (MINCOTUR) in Spain within the Secpho ecosystem. The ministry has awarded over US$3.17 million in grants to the Secpho cluster for innovative projects. 2EyesVision is committed to shaping the future of ophthalmology care technologies. On June 6, 2023, the National Health Service took the initiative to make eye care more accessible to patients in England. Under this initiative, measures were taken to reduce wait times for care, which was tagged as a “top priority.”
Sightsavers—an international nongovernmental organization—works in developing countries to treat and prevent eye diseases. The organization aims to create awareness and provide high-quality eye health services with its Rural Eye Health Programme, thus taking steps to eradicate avoidable blindness in rural populations. In 2019, the WHO launched Universal Health Coverage and Eye Care: Promoting Country Action, an event to provide practical, step-by-step guidance to support Member States of the WHO for planning and implementing the recommendations provided in the WHO’s World Report on Vision. The WHO launched this event to provide integrated people-centered eye care services. Further, the India–US Collaborative Vision Research Program 2020, funded by the Indian Department of Biotechnology and the US NEI, focused on advancing science and technology crucial for understanding, preventing, and treating blinding eye diseases, visual disorders, and associated complications.
The Karolinska Institutet, Sweden, offers grants for promoting research on eye diseases. In 2020, the institute announced US$ 5,913–17,739 (SEK 50,000–150,000) per person funding for new research projects on eye diseases. In December 2022, Research to Prevent Blindness provided an annual grant of US$ 115,000 to the John A. Moran Eye Center at the University of Utah for eyecare research. The funds provided maximum flexibility in developing and expanding eye research programs and fostering creative planning beyond the scope of restricted project grants. Thus, the increasing number of initiatives toward eyecare is likely to offer growth opportunities to the America and Europe eye drops market.
The “America & Europe Eye Drops Market” is segmented on the basis of Drug Class, Application, Purchase Mode, and Geography.
Drug Class Overview
Based on drug class, the America & Europe eye drops market is divided into antibiotics, artificial tears, steroids, and others. The antibiotics segment held the largest market share in 2023. However, the steroids segment is anticipated to register the highest CAGR of 6.4% during the forecast period.
Application Overview
By application, the market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest market share in 2023. However, the eye care segment is anticipated to register the highest CAGR during the forecast period.
Purchase Mode Overview
In terms of purchase mode, the market is bifurcated into prescription and OTC. The prescription segment dominated the market share in 2023, and it is anticipated to register a higher CAGR of 5.5% during the forecast period.
The America & Europe eye drops market is segmented by region into America and Europe. The America regional market is expected to grow with a CAGR of 5.6% during 2023–2031. The America eye drops market is segmented into the US, Canada, Mexico, Brazil, Argentina, Chile, and the Rest of America. The market growth in this region can be attributed to the increasing awareness of dry eyes disease (DED), growing aging population, technological advancements, and rising eye disease cases. Moreover, the easy availability of various drugs due owing to frequent launches of new drugs is one of the key factors propelling the dry eye products market growth in the region. In addition, a growing understanding about of the benefits of eye drops, coupled with developing healthcare infrastructure, contributes to the rapid growth of the eye drops market in America. Europe is expected to register the highest CAGR of 4.9% during 2023–2031. The Europe eye drops market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany held the largest market share in 2023, and France is expected to show a significant growth rate in the market.
America & Europe Eye Drops Market, by Region, 2023 (%)
Source: the Research Team Analysis
Alcon AG; AbbVie Inc; Bausch & Lomb Inc; Pfizer Inc; Prestige Consumer Healthcare Inc.; Similasan Corp; Rohto Pharmaceutical Co Ltd; Sager Pharma Kft; Akorn Operating Company LLC; Santen Pharmaceutical Co., Ltd.; SERVImed Industrial S.p.A.; and I-MED Pharma Inc. are among the leading market players of America & Europe eye drops market. These companies focus on new product launches and geographical expansions to meet the growing consumer demand and increase their product range in specialty portfolios. They have a widespread global presence, which allows them to serve a large set of customers and subsequently increase their market share.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the America & Europe eye drops market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth America & Europe eye drops market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. America and Europe Eye Drops Market Landscape
4.1 Overview
4.2 PEST Analysis
5. America and Europe Eye Drops Market – Key Market Dynamics
5.1 America and Europe Eye Drops Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Ophthalmic Diseases
5.2.2 High Incidence of Age-Related Eye Diseases
5.3 Market Restraints
5.3.1 Rising Number of Product Recalls
5.4 Market Opportunities
5.4.1 Initiatives to Bolster Eye Care Awareness
5.5 Future Trends
5.5.1 Lifestyle Changes Affecting Eye Health
5.6 Impact:
6. America and Europe Eye Drops Market – Regional Market Analysis
6.1 America and Europe Eye Drops Market Revenue (US$ Million), 2023–2031
7. America and Europe Eye Drops Market Analysis – by Drug Class
7.1 Overview
7.2 Antibiotics
7.2.1 Overview
7.2.2 Antibiotics: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Artificial Tears
7.3.1 Overview
7.3.2 Artificial Tears: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Steroids
7.4.1 Overview
7.4.2 Steroids: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
8. America and Europe Eye Drops Market Analysis – by Application
8.1 Overview
8.2 Eye Diseases
8.2.1 Overview
8.2.2 Eye Diseases: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Eye Care
8.3.1 Overview
8.3.2 Eye Care: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
9. America and Europe Eye Drops Market Analysis – by Purchase Mode
9.1 Overview
9.2 Prescription
9.2.1 Overview
9.2.2 Prescription: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
9.3 OTC
9.3.1 Overview
9.3.2 OTC: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10. America and Europe Eye Drops Market – Geographical Analysis
10.1 Overview
10.2 America
10.2.1 America Eye Drops Market Overview
10.2.2 America: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.2.1 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Drug Class
10.2.2.1.1 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Antibiotics
10.2.2.1.2 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Artificial Tears
10.2.2.1.3 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Steroids
10.2.2.2 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Application
10.2.2.2.1 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Eye Diseases
10.2.2.3 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Purchase Mode
10.2.3 America: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Country
10.2.3.1 United States: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.1.1 Overview
10.2.3.1.2 United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.1.3 United States: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.1.3.1 United States: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.1.3.2 United States: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.1.3.3 United States: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.1.4 United States: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.1.4.1 United States: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.1.5 United States: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.2.3.2 Canada: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.2.1 Overview
10.2.3.2.2 Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.2.3 Canada: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.2.3.1 Canada: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.2.3.2 Canada: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.2.3.3 Canada: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.2.4 Canada: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.2.4.1 Canada: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.2.5 Canada: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.2.3.3 Brazil: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.3.1 Overview
10.2.3.3.2 Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.3.3.1 Brazil: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.3.3.2 Brazil: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.3.3.3 Brazil: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.3.4 Brazil: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.3.4.1 Brazil: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.3.5 Brazil: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.2.3.4 Mexico: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.4.1 Overview
10.2.3.4.2 Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.4.3 Mexico: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.4.3.1 Mexico: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.4.3.2 Mexico: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.4.3.3 Mexico: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.4.4 Mexico: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.4.4.1 Mexico: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.4.5 Mexico: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.2.3.5 Argentina: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.5.1 Overview
10.2.3.5.2 Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.5.3 Argentina: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.5.3.1 Argentina: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.5.3.2 Argentina: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.5.3.3 Argentina: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.5.4 Argentina: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.5.4.1 Argentina: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.5.5 Argentina: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.2.3.6 Chile: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.6.1 Overview
10.2.3.6.2 Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.6.3 Chile: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.6.3.1 Chile: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.6.3.2 Chile: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.6.3.3 Chile: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.6.4 Chile: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.6.4.1 Chile: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.6.5 Chile: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.2.3.7 Rest of America: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.7.1 Overview
10.2.3.7.2 Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.7.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Drug Class
10.2.3.7.3.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.2.3.7.3.2 Rest of America: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.2.3.7.3.3 Rest of America: America and Europe Eye Drops Market Breakdown, by Steroids
10.2.3.7.4 Rest of America: America and Europe Eye Drops Market Breakdown, by Application
10.2.3.7.4.1 Rest of America: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.2.3.7.5 Rest of America: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3 Europe
10.3.1 Overview
10.3.2 Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.2.1 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Drug Class
10.3.2.1.1 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Antibiotics
10.3.2.1.2 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Artificial Tears
10.3.2.1.3 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Steroids
10.3.2.2 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Application
10.3.2.2.1 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Eye Diseases
10.3.2.3 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Purchase Mode
10.3.3 Europe: America and Europe Eye Drops Market – Revenue and Forecast Analysis – by Country
10.3.3.1 Germany: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.1.1 Overview
10.3.3.1.2 Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.1.3 Germany: America and Europe Eye Drops Market Breakdown, by Drug Class
10.3.3.1.3.1 Germany: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.3.3.1.3.2 Germany: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.3.3.1.3.3 Germany: America and Europe Eye Drops Market Breakdown, by Steroids
10.3.3.1.4 Germany: America and Europe Eye Drops Market Breakdown, by Application
10.3.3.1.4.1 Germany: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.3.3.1.5 Germany: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3.3.2 France: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.2.1 Overview
10.3.3.2.2 France: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.2.3 France: America and Europe Eye Drops Market Breakdown, by Drug Class
10.3.3.2.3.1 France: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.3.3.2.3.2 France: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.3.3.2.3.3 France: America and Europe Eye Drops Market Breakdown, by Steroids
10.3.3.2.4 France: America and Europe Eye Drops Market Breakdown, by Application
10.3.3.2.4.1 France: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.3.3.2.5 France: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3.3.3 United Kingdom: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.3.1 Overview
10.3.3.3.2 United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Drug Class
10.3.3.3.3.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.3.3.3.3.2 United Kingdom: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.3.3.3.3.3 United Kingdom: America and Europe Eye Drops Market Breakdown, by Steroids
10.3.3.3.4 United Kingdom: America and Europe Eye Drops Market Breakdown, by Application
10.3.3.3.4.1 United Kingdom: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.3.3.3.5 United Kingdom: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3.3.4 Italy: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.4.1 Overview
10.3.3.4.2 Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.4.3 Italy: America and Europe Eye Drops Market Breakdown, by Drug Class
10.3.3.4.3.1 Italy: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.3.3.4.3.2 Italy: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.3.3.4.3.3 Italy: America and Europe Eye Drops Market Breakdown, by Steroids
10.3.3.4.4 Italy: America and Europe Eye Drops Market Breakdown, by Application
10.3.3.4.4.1 Italy: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.3.3.4.5 Italy: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3.3.5 Spain: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.5.1 Overview
10.3.3.5.2 Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.5.3 Spain: America and Europe Eye Drops Market Breakdown, by Drug Class
10.3.3.5.3.1 Spain: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.3.3.5.3.2 Spain: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.3.3.5.3.3 Spain: America and Europe Eye Drops Market Breakdown, by Steroids
10.3.3.5.4 Spain: America and Europe Eye Drops Market Breakdown, by Application
10.3.3.5.4.1 Spain: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.3.3.5.5 Spain: America and Europe Eye Drops Market Breakdown, by Purchase Mode
10.3.3.6 Rest of Europe: Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.6.1 Overview
10.3.3.6.2 Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.6.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Drug Class
10.3.3.6.3.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Antibiotics
10.3.3.6.3.2 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Artificial Tears
10.3.3.6.3.3 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Steroids
10.3.3.6.4 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Application
10.3.3.6.4.1 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Eye Diseases
10.3.3.6.5 Rest of Europe: America and Europe Eye Drops Market Breakdown, by Purchase Mode
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the America and Europe Eye Drops Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Alcon AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AbbVie Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bausch & Lomb Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Prestige Consumer Healthcare Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Similasan Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Rohto Pharmaceutical Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sager Pharma Kft
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Akorn Operating Company LLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Santen Pharmaceutical Co., Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 SERVImed Industrial S.p.A.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 I-MED Pharma Inc.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
13. Appendix
13.1 About the Research Team
LIST OF TABLES
Table 1. America and Europe Eye Drops Market Segmentation
Table 2. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 3. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 4. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 5. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 6. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 7. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 8. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 9. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 10. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 11. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 12. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 13. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 14. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 15. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 16. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 17. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 18. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 19. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 20. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 22. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 23. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 24. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 25. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 26. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 27. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 28. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 29. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 30. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 31. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 32. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 33. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 34. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 35. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 36. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 37. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 38. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 39. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 40. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 41. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 42. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 43. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 44. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 45. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 46. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 47. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 48. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 49. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 50. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 51. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 52. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 53. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 54. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 55. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 57. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 58. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 59. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 60. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 61. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 62. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 63. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 64. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 65. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 66. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 67. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 68. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 69. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 70. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 71. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 72. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 73. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 74. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 75. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 76. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 77. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 78. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 79. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 80. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 81. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 82. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 83. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 84. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 85. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 86. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 87. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 88. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 89. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 90. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 91. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 92. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 93. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 94. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 95. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 96. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 97. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 98. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 99. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 100. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class
Table 101. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Antibiotics
Table 102. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Artificial Tears
Table 103. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Steroids
Table 104. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 105. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Eye Diseases
Table 106. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million) – by Purchase Mode
Table 107. Recent Organic Growth Strategies in the America and Europe Eye Drops Market
Table 108. Recent Inorganic Growth Strategies in the America and Europe Eye Drops Market
LIST OF FIGURES
Figure 1. America and Europe Eye Drops Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. America and Europe Eye Drops Market Revenue (US$ Million), 2023–2031
Figure 5. Eye Drops Market Breakdown by Geography, 2023 and 2031 (%)
Figure 6. America and Europe Eye Drops Market Share (%) – by Drug Class (2023 and 2031)
Figure 7. Antibiotics: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Artificial Tears: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Steroids: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. America and Europe Eye Drops Market Share (%) – by Application (2023 and 2031)
Figure 12. Eye Diseases: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Eye Care: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. America and Europe Eye Drops Market Share (%) – by Purchase Mode (2023 and 2031)
Figure 16. Prescription: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. OTC: America and Europe Eye Drops Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. America and Europe Eye Drops Market Breakdown by Region, 2023 and 2031 (%)
Figure 19. America: Eye Drops Market, by Key Country – Revenue (2023) (US$ Million)
Figure 20. America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 21. America: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. United States: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 23. Canada: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. Brazil: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. Mexico: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. Argentina: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Chile: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Rest of America: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Eye Drops Market, by Key Country – Revenue (2023) (US$ Million)
Figure 30. Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Europe: America and Europe Eye Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 32. Germany: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. France: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. United Kingdom: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Italy: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Spain: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Rest of Europe: America and Europe Eye Drops Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Growth Strategies in the America and Europe Eye Drops Market
The List of Companies – America & Europe Eye Drops Market
o Alcon AG
o AbbVie Inc
o Bausch & Lomb Inc
o Pfizer Inc
o Prestige Consumer Healthcare Inc.
o Similasan Corp
o Rohto Pharmaceutical Co Ltd
o Sager Pharma Kft
o Akorn Operating Company LLC
o Santen Pharmaceutical Co., Ltd.
o SERVImed Industrial S.p.A.
o I-MED Pharma Inc.
o urope Eye Drops Market
You must be logged in to post a review.
Reviews
There are no reviews yet.